{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:49:26Z","timestamp":1740142166420,"version":"3.37.3"},"reference-count":125,"publisher":"Bentham Science Publishers Ltd.","issue":"27","funder":[{"DOI":"10.13039\/501100003329","name":"Spanish Ministry of Economy and Competitivity","doi-asserted-by":"publisher","award":["RETICS RD16\/0008\/0001","FIS-PI13\/02177","PI17CIII\/00045-UFIEC PY 124\/18"],"award-info":[{"award-number":["RETICS RD16\/0008\/0001","FIS-PI13\/02177","PI17CIII\/00045-UFIEC PY 124\/18"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"Europeo de Desarrollo Regional-FEDER","doi-asserted-by":"publisher","award":["SAF2014-53209-R","SAF2016-77084-R"],"award-info":[{"award-number":["SAF2014-53209-R","SAF2016-77084-R"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,8,5]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The eye is a complex organ comprised of several compartments with exclusive and specialized\nproperties that reflect their diverse functions. Although the prevalence of eye pathologies is\nincreasing, mainly because of its correlation with aging and of generalized lifestyle changes, the\npathogenic molecular mechanisms of many common ocular diseases remain poorly understood.\nTherefore, there is an unmet need to delve into the pathogenesis, diagnosis, and treatment\nof eye diseases to preserve ocular health and reduce the incidence of visual impairment or blindness.\nProteomics analysis stands as a valuable tool for deciphering protein profiles related to specific ocular\nconditions. In turn, such profiles can lead to real breakthroughs in the fields of ocular science and\nophthalmology. Among proteomics techniques, protein microarray technology stands out by providing\nexpanded information using very small volumes of samples.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>In this review, we present a brief summary of the main types of protein microarrays and their application\nfor the identification of protein changes in chronic ocular diseases such as dry eye, glaucoma,\nage-related macular degeneration, or diabetic retinopathy. The validation of these specific protein\nalterations could provide new biomarkers, disclose eye diseases pathways, and help in the diagnosis\nand development of novel therapies for eye pathologies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867326666190627131300","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T12:59:02Z","timestamp":1561640342000},"page":"4549-4566","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protein Microarrays: Valuable Tools for Ocular Diseases Research"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-4986","authenticated-orcid":true,"given":"Mar\u00eda","family":"Garranzo-Asensio","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Optics and Optometry, Universidad Complutense de Madrid, C\/Arcos de Jalon 118, Madrid 28037, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5141-0454","authenticated-orcid":true,"given":"Ana","family":"Montero-Calle","sequence":"additional","affiliation":[{"name":"Functional Proteomics Unit, Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4785-0040","authenticated-orcid":true,"given":"Guillermo","family":"Sol\u00eds-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Functional Proteomics Unit, Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3539-7469","authenticated-orcid":true,"given":"Rodrigo","family":"Barderas","sequence":"additional","affiliation":[{"name":"Functional Proteomics Unit, Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6722-2044","authenticated-orcid":true,"given":"Ana","family":"Guzman-Aranguez","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Optics and Optometry, Universidad Complutense de Madrid, C\/Arcos de Jalon 118, Madrid 28037, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"S67","volume":"19(5) (Suppl. .)","author":"Akpek, E.K.","year":"2013","unstructured":"Akpek, E.K.; Smith, R.A. Overview of age-related ocular conditions. Am, J. Manag. Care. 2013,19(5) (Suppl.),S67-S75. PMID: 23725498","journal-title":"Am, J.Manag.Care"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"ORSF5","DOI":"10.1167\/iovs.13-12789","volume":"54(14)","author":"Klein,R.","year":"2013","unstructured":"Klein,R.; Klein, B.E. The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Invest. Ophthalmol. Vis. Sci. 2013,54(14),ORSF5-ORSF13. http:\/\/dx.doi.org\/10.1167\/iovs.13-12789 PMID: 24335069","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e1700394","DOI":"10.1002\/pmic.201700394","volume":"18(5-6)","author":"Ahmad, M.T.","year":"2018","unstructured":"Ahmad, M.T.; Zhang,P.; Dufresne,C.; Ferrucci,L.; Semba, R.D. The human eye proteome project: updates on an emerging proteome. Proteomics. 2018,18(5-6),e1700394. http:\/\/dx.doi.org\/10.1002\/pmic.201700394 PMID: 29356342","journal-title":"Proteomics"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jprot.2016.05.006","volume":"150","author":"Azkargorta,M.","year":"2017","unstructured":"Azkargorta,M.; Soria,J.; Acera,A.; Iloro,I.; Elortza, F. Human tear proteomics and peptidomics in ophthalmology: toward the translation of proteomic biomarkers into clinical practice, J. Proteomics. 2017,150,359-367. http:\/\/dx.doi.org\/10.1016\/j.jprot.2016.05.006 PMID: 27184738","journal-title":"Proteomics"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/elps.201400049","volume":"35(17)","author":"Rocha, A.S.","year":"2014","unstructured":"Rocha, A.S.; Santos, F.M.; Monteiro, J.P.; Castro-de-Sousa, J.P.; Queiroz, J.A.; Tomaz, C.T.; Passarinha, L.A. Trends in proteomic analysis of human vitreous humor samples. Elec-trophoresis. 2014,35(17),2495-2508. http:\/\/dx.doi.org\/10.1002\/elps.201400049 PMID: 24825767","journal-title":"Elec-trophoresis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1444-0938.2007.00194.x","volume":"91(1)","author":"Lam, T.C.","year":"2008","unstructured":"Lam, T.C.; Chun, R.K.; Li, K.K.; To, C.H. Application of proteomic technology in eye research: a mini review. Clin. Exp. Optom. 2008,91(1),23-33. http:\/\/dx.doi.org\/10.1111\/j.1444-0938.2007.00194.x PMID: 18045249","journal-title":"Clin.Exp.Optom"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/prca.201470024","volume":"8(3-4)","author":"Semba, R.D.","year":"2014","unstructured":"Semba, R.D.; Enghild, J.J. Proteomics and the eye. Pro-teomics Clin. Appl. 2014,8(3-4),127-129. http:\/\/dx.doi.org\/10.1002\/prca.201470024 PMID: 24729286","journal-title":"Pro-teomics Clin.Appl"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1038\/s41598-018-24197-2","volume":"8(1)","author":"Fortmann, S.D.","year":"2018","unstructured":"Fortmann, S.D.; Lorenc, V.E.; Shen,J.; Hackett, S.F.; Cam-pochiaro, P.A. Mousetap, a novel technique to collect un-contaminated vitreous or aqueous and expand usefulness of mouse models. Sci. Rep. 2018,8(1),6371. http:\/\/dx.doi.org\/10.1038\/s41598-018-24197-2 PMID: 29686307","journal-title":"Sci.Rep"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ab.2014.01.002","volume":"450","author":"Gonzalez-Gonzalez,M.","year":"2014","unstructured":"Gonzalez-Gonzalez,M.; Bartolome,R.; Jara-Acevedo,R.; Casado-Vela,J.; Dasilva,N.; Matarraz,S.; Garcia,J.; Alca-zar, J.A.; Sayagues, J.M.; Orfao,A.; Fuentes, M. Evaluation of homo-and hetero-functionally activated glass surfaces for optimized antibody arrays. Anal. Biochem. 2014,450,37-45. http:\/\/dx.doi.org\/10.1016\/j.ab.2014.01.002 PMID: 24440232","journal-title":"Anal.Biochem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e51872","DOI":"10.3791\/51872","volume":"(102)","author":"Fasolo,J.","year":"2015","unstructured":"Fasolo,J.; Im,H.; Snyder, M.P. Probing high-density func-tional protein microarrays to detect protein-protein interac-tions, J. Vis. Exp. 2015, (102),e51872. http:\/\/dx.doi.org\/10.3791\/51872 PMID: 26274875","journal-title":"Vis.Exp"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cbpa.2004.12.006","volume":"9(1)","author":"LaBaer,J.","year":"2005","unstructured":"LaBaer,J.; Ramachandran, N. Protein microarrays as tools for functional proteomics. Curr. Opin. Chem. Biol. 2005,9(1),14-19. http:\/\/dx.doi.org\/10.1016\/j.cbpa.2004.12.006 PMID: 15701447","journal-title":"Curr.Opin.Chem.Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"001784","DOI":"10.1074\/mcp.M110.001784","volume":"10(3)","author":"Babel,I.","year":"2011","unstructured":"Babel,I.; Barderas,R.; Diaz-Uriarte,R.; Moreno,V.; Su-arez,A.; Fernandez-Acenero, M.J.; Salazar,R.; Capella,G.; Casal, J.I. Identification of MST1\/STK4 and SULF1 pro-teins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays. Mol. Cell. Proteomics. 2011,10(3),001784. http:\/\/dx.doi.org\/10.1074\/mcp.M110.001784 PMID: 21228115","journal-title":"Mol.Cell.Proteomics"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/omi.2006.10.499","volume":"10(4)","author":"Chatterjee,M.","year":"2006","unstructured":"Chatterjee,M.; Ionan,A.; Draghici,S.; Tainsky, M.A. Epitomics: global profiling of immune response to disease using protein microarrays. OMICS. 2006,10(4),499-506. http:\/\/dx.doi.org\/10.1089\/omi.2006.10.499 PMID: 17233560","journal-title":"OMICS"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1158\/0008-5472.CAN-04-2962","volume":"66(2)","author":"Chatterjee,M.","year":"2006","unstructured":"Chatterjee,M.; Mohapatra,S.; Ionan,A.; Bawa,G.; Ali-Fehmi,R.; Wang,X.; Nowak,J.; Ye,B.; Nahhas, F.A.; Lu,K.; Witkin, S.S.; Fishman,D.; Munkarah,A.; Morris,R.; Levin, N.K.; Shirley, N.N.; Tromp,G.; Abrams,J.; Draghici,S.; Tainsky, M.A. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res. 2006,66(2),1181-1190. http:\/\/dx.doi.org\/10.1158\/0008-5472.CAN-04-2962 PMID: 16424057","journal-title":"Cancer Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1056\/NEJMoa051931","volume":"353(12)","author":"Wang,X.","year":"2005","unstructured":"Wang,X.; Yu,J.; Sreekumar,A.; Varambally,S.; Shen,R.; Giacherio,D.; Mehra,R.; Montie, J.E.; Pienta, K.J.; Sanda, M.G.; Kantoff, P.W.; Rubin, M.A.; Wei, J.T.; Ghosh,D.; Chinnaiyan, A.M. Autoantibody signatures in prostate can-cer, N. Engl, J. Med. 2005,353(12),1224-1235. http:\/\/dx.doi.org\/10.1056\/NEJMoa051931 PMID: 16177248","journal-title":"Engl, J.Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"e23112","DOI":"10.1371\/journal.pone.0023112","volume":"6(8)","author":"Nagele,E.","year":"2011","unstructured":"Nagele,E.; Han,M.; Demarshall,C.; Belinka,B.; Nagele, R. Diagnosis of Alzheimer\u2019s disease based on disease-specific autoantibody profiles in human sera. PLoS One. 2011,6(8),e23112. http:\/\/dx.doi.org\/10.1371\/journal.pone.0023112 PMID: 21826230","journal-title":"PLoS One"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e60726","DOI":"10.1371\/journal.pone.0060726","volume":"8(4)","author":"Nagele, E.P.","year":"2013","unstructured":"Nagele, E.P.; Han,M.; Acharya, N.K.; DeMarshall,C.; Kosciuk, M.C.; Nagele, R.G. Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their num-ber is influenced by age, gender, and disease. PLoS One. 2013,8(4),e60726. http:\/\/dx.doi.org\/10.1371\/journal.pone.0060726 PMID: 23589757","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irn.2015.05.005","volume":"122","author":"DeMarshall,C.","year":"2015","unstructured":"DeMarshall,C.; Sarkar,A.; Nagele, E.P.; Goldwaser,E.; Godsey,G.; Acharya, N.K.; Nagele, R.G. Utility of autoan-tibodies as biomarkers for diagnosis and staging of neu-rodegenerative diseases. Int. Rev. Neurobiol. 2015,122,1-51. http:\/\/dx.doi.org\/10.1016\/bs.irn.2015.05.005 PMID: 26358889","journal-title":"Int.Rev.Neurobiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e32383","DOI":"10.1371\/journal.pone.0032383","volume":"7(2)","author":"Han,M.","year":"2012","unstructured":"Han,M.; Nagele,E.; DeMarshall,C.; Acharya,N.; Nagele, R. Diagnosis of Parkinson\u2019s disease based on disease-specific autoantibody profiles in human sera. PLoS One. 2012,7(2),e32383. http:\/\/dx.doi.org\/10.1371\/journal.pone.0032383 PMID: 22384236","journal-title":"PLoS One"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1016\/j.jprot.2012.03.004","volume":"75(15)","author":"Barderas,R.","year":"2012","unstructured":"Barderas,R.; Babel,I.; Diaz-Uriarte,R.; Moreno,V.; Su-arez,A.; Bonilla,F.; Villar-Vazquez,R.; Capella,G.; Casal, J.I. An optimized predictor panel for colorectal cancer diag-nosis based on the combination of tumor-associated anti-gens obtained from protein and phage microarrays, J. Pro-teomics. 2012,75(15),4647-4655. http:\/\/dx.doi.org\/10.1016\/j.jprot.2012.03.004 PMID: 22465712","journal-title":"Pro-teomics"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1038\/srep02938","volume":"3","author":"Barderas,R.","year":"2013","unstructured":"Barderas,R.; Villar-Vazquez,R.; Fernandez-Acenero, M.J.; Babel,I.; Pelaez-Garcia,A.; Torres,S.; Casal, J.I. Sporadic colon cancer murine models demonstrate the value of autoantibody detection for preclinical cancer diagnosis. Sci. Rep. 2013,3,2938. http:\/\/dx.doi.org\/10.1038\/srep02938 PMID: 24126910","journal-title":"Sci.Rep"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1074\/mcp.M800596-MCP200","volume":"8(10)","author":"Babel,I.","year":"2009","unstructured":"Babel,I.; Barderas,R.; Diaz-Uriarte,R.; Martinez-Torrecuadrada, J.L.; Sanchez-Carbayo,M.; Casal, J.I. Iden-tification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein mi-croarrays. Mol. Cell. Proteomics. 2009,8(10),2382-2395. http:\/\/dx.doi.org\/10.1074\/mcp.M800596-MCP200 PMID: 19638618","journal-title":"Mol.Cell.Proteomics"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/978-1-4939-2550-6_32","volume":"1295","author":"Cox,E.","year":"2015","unstructured":"Cox,E.; Uzoma,I.; Guzzo,C.; Jeong, J.S.; Matunis,M.; Blackshaw,S.; Zhu, H. Identification of SUMO E3 ligase-specific substrates using the HuProt human proteome mi-croarray. Methods Mol. Biol. 2015,1295,455-463. http:\/\/dx.doi.org\/10.1007\/978-1-4939-2550-6_32 PMID: 25820740","journal-title":"Methods Mol.Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1074\/mcp.M112.026757","volume":"12(9)","author":"Ayoglu,B.","year":"2013","unstructured":"Ayoglu,B.; Haggmark,A.; Khademi,M.; Olsson,T.; Uhlen,M.; Schwenk, J.M.; Nilsson, P. Autoantibody profil-ing in multiple sclerosis using arrays of human protein fragments. Mol. Cell. Proteomics. 2013,12(9),2657-2672. http:\/\/dx.doi.org\/10.1074\/mcp.M112.026757 PMID: 23732997","journal-title":"Mol.Cell.Proteomics"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347(6220)","author":"Uhlen,M.","year":"2015","unstructured":"Uhlen,M.; Fagerberg,L.; Hallstrom, B.M.; Lindskog,C.; Oksvold,P.; Mardinoglu,A.; Sivertsson,A.; Kampf,C.; Sjostedt,E.; Asplund,A.; Olsson,I.; Edlund,K.; Lundberg,E.; Navani,S.; Szigyarto, C.A.; Odeberg,J.; Djureinovic,D.; Takanen, J.O.; Hober,S.; Alm,T.; Edqvist, P.H.; Ber-ling,H.; Tegel,H.; Mulder,J.; Rockberg,J.; Nilsson,P.; Schwenk, J.M.; Hamsten,M.; von Feilitzen,K.; Forsberg,M.; Persson,L.; Johansson,F.; Zwahlen,M.; von Heijne,G.; Nielsen,J.; Ponten, F. Proteomics. Tissue-based map of the human proteome. Science. 2015,347(6220),1260419. http:\/\/dx.doi.org\/10.1126\/science.1260419 PMID: 25613900","journal-title":"Tissue-based map of the human proteome.Science"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","volume":"28(12)","author":"Uhlen,M.","year":"2010","unstructured":"Uhlen,M.; Oksvold,P.; Fagerberg,L.; Lundberg,E.; Jonas-son,K.; Forsberg,M.; Zwahlen,M.; Kampf,C.; Wester,K.; Hober,S.; Wernerus,H.; Bjorling,L.; Ponten, F. Towards a knowledge-based human protein atlas. Nat. Biotechnol. 2010,28(12),1248-1250. http:\/\/dx.doi.org\/10.1038\/nbt1210-1248 PMID: 21139605","journal-title":"Nat.Biotechnol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"10847","DOI":"10.18632\/oncotarget.24303","volume":"9(13)","author":"Garranzo-Asensio,M.","year":"2018","unstructured":"Garranzo-Asensio,M.; San Segundo-Acosta,P.; Martinez-Useros,J.; Montero-Calle,A.; Fernandez-Acenero, M.J.; Haggmark-Manberg,A.; Pelaez-Garcia,A.; Villalba,M.; Rabano,A.; Nilsson,P.; Barderas, R. Identification of pre-frontal cortex protein alterations in Alzheimer\u2019s disease. Oncotarget. 2018,9(13),10847-10867. http:\/\/dx.doi.org\/10.18632\/oncotarget.24303 PMID: 29541381","journal-title":"Oncotarget"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.euprot.2014.02.012","volume":"3","author":"Ahn, S.B.","year":"2014","unstructured":"Ahn, S.B.; Khan, A. Detection and quantitation of twenty-seven cytokines, chemokines and growth factors pre-and post-high abundance protein depletion in human plasma. EuPA Open Proteom. 2014,3,78-84. http:\/\/dx.doi.org\/10.1016\/j.euprot.2014.02.012","journal-title":"EuPA Open Proteom"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/onc.2013.548","volume":"34(1)","author":"Stampolidis,P.","year":"2015","unstructured":"Stampolidis,P.; Ullrich,A.; Iacobelli, S. LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes on-cogenic cellular events impeded by antibody intervention. Oncogene. 2015,34(1),39-52. http:\/\/dx.doi.org\/10.1038\/onc.2013.548 PMID: 24362527","journal-title":"Oncogene"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2144\/000114028","volume":"54(5)","author":"Yu,X.","year":"2013","unstructured":"Yu,X.; Wallstrom,G.; Magee, D.M.; Qiu,J.; Mendoza, D.E.A.; Wang,J.; Bian,X.; Graves,M.; LaBaer, J. Quanti-fying antibody binding on protein microarrays using mi-croarray nonlinear calibration. Biotechniques. 2013,54(5),257-264. http:\/\/dx.doi.org\/10.2144\/000114028 PMID: 23662896","journal-title":"Biotechniques"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/microarrays3040282","volume":"3(4)","author":"Hospach,I.","year":"2014","unstructured":"Hospach,I.; Joseph,Y.; Mai, M.K.; Krasteva,N.; Nelles, G. Fabrication of homogeneous high-density antibody microar-rays for cytokine detection. Microarrays (Basel). 2014,3(4),282-301. http:\/\/dx.doi.org\/10.3390\/microarrays3040282 PMID: 27600349","journal-title":"Microarrays (Basel)"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1158\/0008-5472.CAN-11-4090","volume":"72(11)","author":"Barderas,R.","year":"2012","unstructured":"Barderas,R.; Bartolome, R.A.; Fernandez-Acenero, M.J.; Torres,S.; Casal, J.I. High expression of IL-13 receptor 2 in colorectal cancer is associated with invasion, liver metas-tasis, and poor prognosis. Cancer Res. 2012,72(11),2780-2790. http:\/\/dx.doi.org\/10.1158\/0008-5472.CAN-11-4090 PMID: 22505647","journal-title":"Cancer Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-1759(01) 00394-5","volume":"255(1-2)","author":"Huang,R.P","year":"2001","unstructured":"Huang.; R.P. Detection of multiple proteins in an anti body-based protein microarray system, J. Immunol. Methods. 2001,255(1-2),1-13. http:\/\/dx.doi.org\/10.1016\/S0022-1759(01) 00394-5 PMID: 11470281","journal-title":"Immunol.Methods"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-016-0095-2","volume":"11","author":"Jaeger, P.A.","year":"2016","unstructured":"Jaeger, P.A.; Lucin, K.M.; Britschgi,M.; Vardarajan,B.; Huang, R.P.; Kirby, E.D.; Abbey,R.; Boeve, B.F.; Boxer, A.L.; Farrer, L.A.; Finch,N.; Graff-Radford, N.R.; Head,E.; Hofree,M.; Huang,R.; Johns,H.; Karydas,A.; Knop-man, D.S.; Loboda,A.; Masliah,E.; Narasimhan,R.; Peter-sen, R.C.; Podtelezhnikov,A.; Pradhan,S.; Rademakers,R.; Sun, C.H.; Younkin, S.G.; Miller, B.L.; Ideker,T.; Wyss-Coray, T. Network-driven plasma proteomics expose mo-lecular changes in the Alzheimer\u2019s brain. Mol. Neurode-gener. 2016,11,31. http:\/\/dx.doi.org\/10.1186\/s13024-016-0095-2 PMID: 27112350","journal-title":"Mol.Neurode-gener"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1074\/mcp.M700006-MCP200","volume":"6(12)","author":"Madoz-Gurpide,J.","year":"2007","unstructured":"Madoz-Gurpide,J.; Canamero,M.; Sanchez,L.; Solano,J.; Alfonso,P.; Casal, J.I. A proteomics analysis of cell signal-ing alterations in colorectal cancer. Mol. Cell. Proteomics. 2007,6(12),2150-2164. http:\/\/dx.doi.org\/10.1074\/mcp.M700006-MCP200 PMID: 17848589","journal-title":"Mol.Cell.Proteomics"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1038\/onc.2009.285","volume":"28(49)","author":"Pena,C.","year":"2009","unstructured":"Pena,C.; Garcia, J.M.; Larriba, M.J.; Barderas,R.; Gomez,I.; Herrera,M.; Garcia,V.; Silva,J.; Dominguez,G.; Rodri-guez,R.; Cuevas,J.; de Herreros, A.G.; Casal, J.I.; Munoz,A.; Bonilla, F. SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene. 2009,28(49),4375-4385. http:\/\/dx.doi.org\/10.1038\/onc.2009.285 PMID: 19802011","journal-title":"Oncogene"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1472-6750-11-61","volume":"11","author":"Babel,I.","year":"2011","unstructured":"Babel,I.; Barderas,R.; Pelaez-Garcia,A.; Casal, J.I. Anti-bodies on demand: a fast method for the production of hu-man scFvs with minimal amounts of antigen. BMC Biotech-nol. 2011,11,61. http:\/\/dx.doi.org\/10.1186\/1472-6750-11-61 PMID: 21635725","journal-title":"BMC Biotech-nol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e0159138","DOI":"10.1371\/journal.pone.0159138","volume":"11(7)","author":"Delfani,P.","year":"2016","unstructured":"Delfani,P.; Dexlin Mellby,L.; Nordstrom,M.; Holmer,A.; Ohlsson,M.; Borrebaeck, C.A.; Wingren, C. Technical ad-vances of the recombinant antibody microarray technology platform for clinical immunoproteomics. PLoS One. 2016,11(7),e0159138. http:\/\/dx.doi.org\/10.1371\/journal.pone.0159138 PMID: 27414037","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jprot.2009.01.027","volume":"72(6)","author":"Borrebaeck, C.A.","year":"2009","unstructured":"Borrebaeck, C.A.; Wingren, C. Design of high-density anti-body microarrays for disease proteomics: key technological issues, J. Proteomics. 2009,72(6),928-935. http:\/\/dx.doi.org\/10.1016\/j.jprot.2009.01.027 PMID: 19457338","journal-title":"Proteomics"},{"key":"ref=40","first-page":"100","volume":"9(3)","author":"Ekins,R.","year":"1997","unstructured":"Ekins,R.; Chu, F. Immunoassay and other ligand assays: present status and future trends, J. Int. Fed. Clin. Chem. 1997,9(3),100-109. PMID: 10174621","journal-title":"Int.Fed..Clin.Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15(3)","author":"Bron, A.J.","year":"2017","unstructured":"Bron, A.J.; de Paiva, C.S.; Chauhan, S.K.; Bonini,S.; Gabi-son, E.E.; Jain,S.; Knop,E.; Markoulli,M.; Ogawa,Y.; Perez,V.; Uchino,Y.; Yokoi,N.; Zoukhri,D.; Sullivan, D.A. TFOS DEWS II pathophysiology report. Ocul. Surf. 2017,15(3),438-510. http:\/\/dx.doi.org\/10.1016\/j.jtos.2017.05.011 PMID: 28736340","journal-title":"Ocul.Surf"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jtos.2017.05.005","volume":"15(3)","author":"Nelson, J.D.","year":"2017","unstructured":"Nelson, J.D.; Craig, J.P.; Akpek, E.K.; Azar, D.T.; Belmonte,C.; Bron, A.J.; Clayton, J.A.; Dogru,M.; Dua, H.S.; Foulks, G.N.; Gomes, J.A.P.; Hammitt, K.M.; Holo-painen,J.; Jones,L.; Joo, C.K.; Liu,Z.; Nichols, J.J.; Nich-ols, K.K.; Novack, G.D.; Sangwan,V.; Stapleton,F.; Tom-linson,A.; Tsubota,K.; Willcox, M.D.P.; Wolffsohn, J.S.; Sullivan, D.A. TFOS DEWS II intr oduction. Ocul. Surf. 2017,15(3),269-275. http:\/\/dx.doi.org\/10.1016\/j.jtos.2017.05.005 PMID: 28736334","journal-title":"Ocul.Surf"},{"key":"ref=43","first-page":"240","volume":"9(2)","author":"Hessen,M.","year":"2014","unstructured":"Hessen,M.; Akpek, E.K. Dry eye: an inflammatory ocular disease, J. Ophthalmic Vis. Res. 2014,9(2),240-250. PMID: 25279127","journal-title":"Ophthalmic Vis.Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","volume":"130(1)","author":"Stevenson,W.","year":"2012","unstructured":"Stevenson,W.; Chauhan, S.K.; Dana, R. Dry eye disease: an immune-mediated ocular surface disorder. Arch. Oph-thalmol. 2012,130(1),90-100. http:\/\/dx.doi.org\/10.1001\/archophthalmol.2011.364 PMID: 22232476","journal-title":"Arch.Oph-thalmol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1167\/iovs.03-0270","volume":"44(11)","author":"Begley, C.G.","year":"2003","unstructured":"Begley, C.G.; Chalmers, R.L.; Abetz,L.; Venkataraman,K.; Mertzanis,P.; Caffery, B.A.; Snyder,C.; Edrington,T.; Nelson,D.; Simpson, T. The relationship between habitual patient-reported symptoms and clinical signs among pa-tients with dry eye of varying severity. Invest. Ophthalmol. Vis. Sci. 2003,44(11),4753-4761. http:\/\/dx.doi.org\/10.1167\/iovs.03-0270 PMID: 14578396","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","volume":"23(8)","author":"Nichols, K.K.","year":"2004","unstructured":"Nichols, K.K.; Nichols, J.J.; Mitchell, G.L. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004,23(8),762-770. http:\/\/dx.doi.org\/10.1097\/01.ico.0000133997.07144.9e PMID: 15502475","journal-title":"Cornea"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1002\/pmic.200600284","volume":"6(23)","author":"Hu,S.","year":"2006","unstructured":"Hu,S.; Loo, J.A.; Wong, D.T. Human body fluid proteome analysis. Proteomics. 2006,6(23),6326-6353. http:\/\/dx.doi.org\/10.1002\/pmic.200600284 PMID: 17083142","journal-title":"Proteomics"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/OPX.0b013e3181824e20","volume":"85(8)","author":"Li,S.","year":"2008","unstructured":"Li,S.; Sack,R.; Vijmasi,T.; Sathe,S.; Beaton,A.; Quigley,D.; Gallup,M.; McNamara, N.A. Antibody protein array analysis of the tear film cytokines. Optom. Vis. Sci. 2008,85(8),653-660. http:\/\/dx.doi.org\/10.1097\/OPX.0b013e3181824e20 PMID: 18677223","journal-title":"Optom.Vis.Sci"},{"key":"ref=49","first-page":"177","volume":"22","author":"Dionne,K.","year":"2016","unstructured":"Dionne,K.; Redfern, R.L.; Nichols, J.J.; Nichols, K.K. Analysis of tear inflammatory mediators: a comparison be-tween the microarray and Luminex methods. Mol. Vis. 2016,22,177-188 PMID: 26957901","journal-title":"Mol..Vis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"7725","DOI":"10.1167\/iovs.11-7266","volume":"52(10)","author":"Boehm,N.","year":"2011","unstructured":"Boehm,N.; Riechardt, A.I.; Wiegand,M.; Pfeiffer,N.; Grus, F.H. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest. Ophthalmol. Vis. Sci. 2011,52(10),7725-7730. http:\/\/dx.doi.org\/10.1167\/iovs.11-7266 PMID: 21775656","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","volume":"147(2)","author":"Lam,H.","year":"2009","unstructured":"Lam,H.; Bleiden,L.; de Paiva, C.S.; Farley,W.; Stern, M.E.; Pflugfelder, S.C.; Farley,W.; Stern, M.E.; Pflugfelder, S.C. Tear cytokine profiles in dysfunctional tear syndrome. Am, J. Ophthalmol. 2009,147(2),198-205. http:\/\/dx.doi.org\/10.1016\/j.ajo.2008.08.032 PMID: 18992869","journal-title":"Am, J.Ophthalmol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","volume":"28(9)","author":"Massingale, M.L.","year":"2009","unstructured":"Massingale, M.L.; Li,X.; Vallabhajosyula,M.; Chen,D.; Wei,Y.; Asbell, P.A. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009,28(9),1023-1027. http:\/\/dx.doi.org\/10.1097\/ICO.0b013e3181a16578 PMID: 19724208","journal-title":"Cornea"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1167\/iovs.11-9417","volume":"53(9)","author":"Na, K.S.","year":"2012","unstructured":"Na, K.S.; Mok, J.W.; Kim, J.Y.; Rho, C.R.; Joo, C.K. Cor-relations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest. Ophthalmol. Vis. Sci. 2012,53(9),5443-5450. http:\/\/dx.doi.org\/10.1167\/iovs.11-9417 PMID: 22789923","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1167\/iovs.11-9054","volume":"53(8)","author":"Huang, J.F.","year":"2012","unstructured":"Huang, J.F.; Zhang,Y.; Rittenhouse, K.D.; Pickering, E.H.; McDowell, M.T. Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease. Invest. Ophthalmol. Vis. Sci. 2012,53(8),4556-4564. http:\/\/dx.doi.org\/10.1167\/iovs.11-9054 PMID: 22695964","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=55","first-page":"862","volume":"16","author":"Enriquez-de-Salamanca,A.","year":"2010","unstructured":"Enriquez-de-Salamanca,A.; Castellanos,E.; Stern, M.E.; Fernandez,I.; Carreno,E.; Garcia-Vazquez,C.; Herreras, J.M.; Calonge, M. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye dis-ease. Mol. Vis. 2010,16,862-873 PMID: 20508732","journal-title":"Mol..Vis"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/ICO.0000000000000721","volume":"35(3)","author":"Meadows, J.F.","year":"2016","unstructured":"Meadows, J.F.; Dionne,K.; Nichols, K.K. Differential pro-filing of T-cell cytokines as measured by protein microarray across dry eye subgroups. Cornea. 2016,35(3),329-335. http:\/\/dx.doi.org\/10.1097\/ICO.0000000000000721 PMID: 26751989","journal-title":"Cornea"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1167\/iovs.11-7627","volume":"53(3)","author":"VanDerMeid, K.R.","year":"2012","unstructured":"VanDerMeid, K.R.; Su, S.P.; Ward, K.W.; Zhang, J.Z. Cor-relation of tear inflammatory cytokines and matrix metallo-proteinases with four dry eye diagnostic tests. Invest. Oph-thalmol. Vis. Sci. 2012,53(3),1512-1518. http:\/\/dx.doi.org\/10.1167\/iovs.11-7627 PMID: 22323462","journal-title":"Invest.Oph-thalmol.Vis.Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ajo.2015.09.039","volume":"161","author":"Lopez-Miguel,A.","year":"2016","unstructured":"Lopez-Miguel,A.; Teson,M.; Martin-Montanez,V.; Enri-quez-de-Salamanca,A.; Stern, M.E.; Gonzalez-Garcia, M.J.; Calonge, M. Clinical and molecular inflammatory re-sponse in sjogren syndrome-associated dry eye patients un-der desiccating stress. Am, J. Ophthalmol. 2016,161,133-141. http:\/\/dx.doi.org\/10.1016\/j.ajo.2015.09.039 PMID: 26456254","journal-title":"Am, J.Ophthalmol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1167\/iovs.12-11361","volume":"54(3)","author":"Teson,M.","year":"2013","unstructured":"Teson,M.; Gonzalez-Garcia, M.J.; Lopez-Miguel,A.; Enri-quez-de-Salamanca,A.; Martin-Montanez,V.; Benito, M.J.; Mateo, M.E.; Stern, M.E.; Calonge, M. Influence of a con-trolled environment simulating an in-flight airplane cabin on dry eye disease. Invest. Ophthalmol. Vis. Sci. 2013,54(3),2093-2099. http:\/\/dx.doi.org\/10.1167\/iovs.12-11361 PMID: 23412090","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","volume":"156(2)","author":"Lee, S.Y.","year":"2013","unstructured":"Lee, S.Y.; Han, S.J.; Nam, S.M.; Yoon, S.C.; Ahn, J.M.; Kim, T.I.; Kim, E.K.; Seo, K.Y. Analysis of tear cytokines and clinical correlations in Sjogren syndrome dry eye pa-tients and non-Sjogren syndrome dry eye patients. Am, J. Ophthalmol. 2013,156(2),247-253. http:\/\/dx.doi.org\/10.1016\/j.ajo.2013.04.003 PMID: 23752063","journal-title":"Am, J.Ophthalmol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e0173301","DOI":"10.1371\/journal.pone.0173301","volume":"12(4)","author":"Liu,R.","year":"2017","unstructured":"Liu,R.; Gao,C.; Chen,H.; Li,Y.; Jin,Y.; Qi, H. Analysis of Th17-associated cytokines and clinical correlations in pa-tients with dry eye disease. PLoS One. 2017,12(4),e0173301. http:\/\/dx.doi.org\/10.1371\/journal.pone.0173301 PMID: 28379971","journal-title":"PLoS One"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.0300-9475.2004.01432.x","volume":"59(6)","author":"Szodoray,P.","year":"2004","unstructured":"Szodoray,P.; Alex,P.; Brun, J.G.; Centola,M.; Jonsson, R. Circulating cytokines in primary Sjogren\u2019s syndrome de-termined by a multiplex cytokine array system. Scand, J. Immunol. 2004,59(6),592-599. http:\/\/dx.doi.org\/10.1111\/j.0300-9475.2004.01432.x PMID: 15182255","journal-title":"Scand, J.Immunol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cellimm.2009.05.013","volume":"259(1)","author":"Giron-Gonzalez, J.A.","year":"2009","unstructured":"Giron-Gonzalez, J.A.; Baturone,R.; Soto, M.J.; Marquez,M.; Macias,I.; Montes-de Oca,M.; Medina,F.; Chozas,N.; Garcia-Perez, S. Implications of immunomodulatory inter-leukins for the hyperimmunoglobulinemia of Sjogren\u2019s syn-drome. Cell. Immunol. 2009,259(1),56-60. http:\/\/dx.doi.org\/10.1016\/j.cellimm.2009.05.013 PMID: 19540455","journal-title":"Cell.Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/02713683.2016.1214966","volume":"42(4)","author":"Ali,M.","year":"2017","unstructured":"Ali,M.; Shah,D.; Pasha,Z.; Jassim, S.H.; Jassim Jaboori,A.; Setabutr,P.; Aakalu, V.K. Evaluation of accessory lac-rimal gland in Muller\u2019s muscle conjunctival resection specimens for precursor cell markers and biological markers of dry eye disease. Curr. Eye Res. 2017,42(4),491-497. http:\/\/dx.doi.org\/10.1080\/02713683.2016.1214966 PMID: 27612554","journal-title":"Curr.Eye Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1167\/iovs.12-10648","volume":"54(1)","author":"Li,Z.","year":"2013","unstructured":"Li,Z.; Woo, J.M.; Chung, S.W.; Kwon, M.Y.; Choi, J.S.; Oh, H.J.; Yoon, K.C. Therapeutic effect of topical adi-ponectin in a mouse model of desiccating stress-induced dry eye. Invest. Ophthalmol. Vis. Sci. 2013,54(1),155-162. http:\/\/dx.doi.org\/10.1167\/iovs.12-10648 PMID: 23211823","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.ophtha.2012.03.017","volume":"119(7)","author":"Huang, J.F.","year":"2012","unstructured":"Huang, J.F.; Yafawi,R.; Zhang,M.; McDowell,M.; Ritten-house, K.D.; Sace,F.; Liew, S.H.; Cooper, S.R.; Pickering, E.H. Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550)  in patients with dry eye disease. Ophthalmology. 2012,119(7),e43-e50. http:\/\/dx.doi.org\/10.1016\/j.ophtha.2012.03.017 PMID: 22607938","journal-title":"Ophthalmology"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ajo.2012.06.009","volume":"154(6)","author":"Lee,H.","year":"2012","unstructured":"Lee,H.; Min,K.; Kim, E.K.; Kim, T.I. Minocycline con-trols clinical outcomes and inflammatory cytokines in mod-erate and severe meibomian gland dysfunction Am, J. Oph-thalmol. 2012,154(6),949-957. http:\/\/dx.doi.org\/10.1016\/j.ajo.2012.06.009","journal-title":"Oph-thalmol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0039-6257(97) 00119-7","volume":"42(4)","author":"Rabinowitz,Y.S","year":"1998","unstructured":"Rabinowitz.; Y.S. Keratoconus. Surv. Ophthalmol. 1998,42(4),297-319. http:\/\/dx.doi.org\/10.1016\/S0039-6257(97) 00119-7 PMID: 9493273","journal-title":"Surv.Ophthalmol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1111\/j.1755-3768.2011.02369.x","volume":"90(4)","author":"Balasubramanian, S.A.","year":"2012","unstructured":"Balasubramanian, S.A.; Mohan,S.; Pye, D.C.; Willcox, M.D. Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus. Acta Ophthalmol. 2012,90(4),e303-e309. http:\/\/dx.doi.org\/10.1111\/j.1755-3768.2011.02369.x PMID: 22413749","journal-title":"Acta Ophthalmol"},{"key":"ref=70","first-page":"1949","volume":"16","author":"Pannebaker,C.","year":"2010","unstructured":"Pannebaker,C.; Chandler, H.L.; Nichols, J.J. Tear pro-teomics in keratoconus. Mol. Vis. 2010,16,1949-1957 PMID: 21031023","journal-title":"Mol..Vis"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/cxo.12118","volume":"97(3)","author":"Cheung, I.M.","year":"2014","unstructured":"Cheung, I.M.; McGhee, C.N.; Sherwin, T. Deficient repair regulatory response to injury in keratoconic stromal cells. Clin. Exp. Optom. 2014,97(3),234-239. http:\/\/dx.doi.org\/10.1111\/cxo.12118 PMID: 24147544","journal-title":"Clin.Exp.Optom"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(10) 61423-7","volume":"377(9774)","author":"Quigley,H.A","year":"2011","unstructured":"Quigley.; H.A. Glaucoma. Lancet. 2011,377(9774),1367-1377. http:\/\/dx.doi.org\/10.1016\/S0140-6736(10) 61423-7 PMID: 21453963","journal-title":"Lancet"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.preteyeres.2016.12.003","volume":"57","author":"Sun,X.","year":"2017","unstructured":"Sun,X.; Dai,Y.; Chen,Y.; Yu, D.Y.; Cringle, S.J.; Chen,J.; Kong,X.; Wang,X.; Jiang, C. Primary angle closure glaucoma: what we know and what we don\u2019t know. Prog. Retin. Eye Res. 2017,57,26-45. https:\/\/dx.doi.org\/10.1016\/j.preteyeres.2016.12.003 PMID: 28039061","journal-title":"Prog.Retin.Eye Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.2174\/1381612821666150909095553","volume":"21(32)","author":"Bucolo,C.","year":"2015","unstructured":"Bucolo,C.; Platania, C.B.; Reibaldi,M.; Bonfiglio,V.; Longo,A.; Salomone,S.; Drago, F. Controversies in glau-coma: current medical treatment and drug development. Curr. Pharm. Des. 2015,21(32),4673-4681. http:\/\/dx.doi.org\/10.2174\/1381612821666150909095553 PMID: 26350532","journal-title":"Curr.Pharm.Des"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1021\/pr1005372","volume":"9(9)","author":"Izzotti,A.","year":"2010","unstructured":"Izzotti,A.; Longobardi,M.; Cartiglia,C.; Sacca, S.C. Pro-teome alterations in primary open angle glaucoma aqueous humor, J. Proteome Res. 2010,9(9),4831-4838. http:\/\/dx.doi.org\/10.1021\/pr1005372 PMID: 20666514","journal-title":"Proteome Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12325-016-0285-x","volume":"33(2)","author":"Micera,A.","year":"2016","unstructured":"Micera,A.; Quaranta,L.; Esposito,G.; Floriani,I.; Poco-belli,A.; Sacca, S.C.; Riva,I.; Manni,G.; Oddone, F. Dif-ferential protein expression profiles in glaucomatous trabe-cular meshwork: an evaluation study on a small primary open angle glaucoma population. Adv. Ther. 2016,33(2),252-267. http:\/\/dx.doi.org\/10.1007\/s12325-016-0285-x PMID: 26820987","journal-title":"Adv.Ther"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1167\/iovs.10-5216","volume":"51(12)","author":"Kuchtey,J.","year":"2010","unstructured":"Kuchtey,J.; Rezaei, K.A.; Jaru-Ampornpan,P.; Sternberg, P. Jr; Kuchtey, R.W. Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Invest. Ophthalmol. Vis. Sci. 2010,51(12),6441-6447. http:\/\/dx.doi.org\/10.1167\/iovs.10-5216 PMID: 20592224","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbi.2011.07.241","volume":"26(1)","author":"Boehm,N.","year":"2012","unstructured":"Boehm,N.; Wolters,D.; Thiel,U.; Lossbrand,U.; Wiegel,N.; Pfeiffer,N.; Grus, F.H. New insights into autoantibody profiles from immune privileged sites in the eye: a glau-coma study. Brain Behav. Immun. 2012,26(1),96-102. http:\/\/dx.doi.org\/10.1016\/j.bbi.2011.07.241 PMID: 21843631","journal-title":"Brain Behav.Immun"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1167\/iovs.09-4898","volume":"51(6)","author":"Dervan, E.W.","year":"2010","unstructured":"Dervan, E.W.; Chen,H.; Ho, S.L.; Brummel,N.; Schmid,J.; Toomey,D.; Haralambova,M.; Gould,E.; Wallace, D.M.; Prehn, J.H.; O\u2019Brien, C.J.; Murphy, D. Protein mac-roarray profiling of serum autoantibodies in pseudoexfolia-tion glaucoma. Invest. Ophthalmol. Vis. Sci. 2010,51(6),2968-2975. http:\/\/dx.doi.org\/10.1167\/iovs.09-4898 PMID: 20107165","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"e57557","DOI":"10.1371\/journal.pone.0057557","volume":"8(2)","author":"Gramlich, O.W.","year":"2013","unstructured":"Gramlich, O.W.; Beck,S.; von Thun Und Hohenstein-Blaul,N.; Boehm,N.; Ziegler,A.; Vetter, J.M.; Pfeiffer,N.; Grus, F.H. Enhanced insight into the autoimmune compo-nent of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina. PLoS One. 2013,8(2),e57557. http:\/\/dx.doi.org\/10.1371\/journal.pone.0057557 PMID: 23451242","journal-title":"PLoS One"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/ceo.12864","volume":"45(3)","author":"Lorenz,K.","year":"2017","unstructured":"Lorenz,K.; Beck,S.; Keilani, M.M.; Wasielica-Poslednik,J.; Pfeiffer,N.; Grus, F.H. Course of serum autoantibodies in patients after acute angle-closure glaucoma attack. Clin. Exp. Ophthalmol. 2017,45(3),280-287. https:\/\/dx.doi.org\/10.1111\/ceo.12864 PMID: 27758063","journal-title":"Clin.Exp.Ophthalmol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12974-016-0542-6","volume":"13(1)","author":"Gramlich, O.W.","year":"2016","unstructured":"Gramlich, O.W.; Teister,J.; Neumann,M.; Tao,X.; Beck,S.; von Pein, H.D.; Pfeiffer,N.; Grus, F.H. Immune re-sponse after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma, J. Neuroinflammation. 2016,13(1),82. http:\/\/dx.doi.org\/10.1186\/s12974-016-0542-6 PMID: 27090083","journal-title":"Neuroinflammation"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/bjophthalmol-2013-304584","volume":"98(11)","author":"Kim, J.M.","year":"2014","unstructured":"Kim, J.M.; Kyung,H.; Azarbod,P.; Lee, J.M.; Caprioli, J. Disc haemorrhage is associated with the fast component, but not the slow component, of visual field decay rate in glaucoma. Br, J. Ophthalmol. 2014,98(11),1555-1559. http:\/\/dx.doi.org\/10.1136\/bjophthalmol-2013-304584 PMID: 24990873","journal-title":"Br, J.Ophthalmol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"e0166813","DOI":"10.1371\/journal.pone.0166813","volume":"11(12)","author":"Lorenz,K.","year":"2016","unstructured":"Lorenz,K.; Beck,S.; Keilani, M.M.; Wasielica-Poslednik,J.; Pfeiffer,N.; Grus, F.H. Longitudinal analysis of serum autoantibody-reactivities in patients with primary open an-gle glaucoma and optic disc hemorrhage. PLoS One. 2016,11(12),e0166813. http:\/\/dx.doi.org\/10.1371\/journal.pone.0166813 PMID: 28030545","journal-title":"PLoS One"},{"author":"Wong, W.L.","key":"ref=85","unstructured":"Wong, W.L.; Su,X.; Li,X.; Cheung, C.M.; Klein,R.; Cheng, C.Y.; Wong, T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and. 2040: a systematic review and meta-analysis. Lancet Glob. Health. 2014,2(2),e106-e116. http:\/\/dx.doi.org\/10.1016\/S2214-109X(13) 70145-1 PMID: 25104651"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","volume":"54","author":"Lambert, N.G.","year":"2016","unstructured":"Lambert, N.G.; ElShelmani,H.; Singh, M.K.; Mansergh, F.C.; Wride, M.A.; Padilla,M.; Keegan,D.; Hogg, R.E.; Ambati, B.K. Risk factors and biomarkers of age-related macular degeneration. Prog. Retin. Eye Res. 2016,54,64-102. http:\/\/dx.doi.org\/10.1016\/j.preteyeres.2016.04.003 PMID: 27156982","journal-title":"Prog.Retin.Eye Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/138945011794182674","volume":"12(2)","author":"Campa,C.","year":"2011","unstructured":"Campa,C.; Harding, S.P. Anti-VEGF compounds in the treatment of neovascular age related macular degeneration. Curr. Drug Targets. 2011,12(2),173-181. http:\/\/dx.doi.org\/10.2174\/138945011794182674 PMID: 20887245","journal-title":"Curr.Drug Targets"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature08151","volume":"460(7252)","author":"Takeda,A.","year":"2009","unstructured":"Takeda,A.; Baffi, J.Z.; Kleinman, M.E.; Cho, W.G.; No-zaki,M.; Yamada,K.; Kaneko,H.; Albuquerque, R.J.; Dridi,S.; Saito,K.; Raisler, B.J.; Budd, S.J.; Geisen,P.; Munitz,A.; Ambati, B.K.; Green, M.G.; Ishibashi,T.; Wright, J.D.; Humbles, A.A.; Gerard, C.J.; Ogura,Y.; Pan,Y.; Smith, J.R.; Grisanti,S.; Hartnett, M.E.; Rothenberg, M.E.; Ambati, J. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature. 2009,460(7252),225-230. http:\/\/dx.doi.org\/10.1038\/nature08151 PMID: 19525930","journal-title":"Nature"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","volume":"3(11)","author":"Saint-Geniez,M.","year":"2008","unstructured":"Saint-Geniez,M.; Maharaj, A.S.; Walshe, T.E.; Tucker, B.A.; Sekiyama,E.; Kurihara,T.; Darland, D.C.; Young, M.J.; D\u2019Amore, P.A. Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One. 2008,3(11),e3554. http:\/\/dx.doi.org\/10.1371\/journal.pone.0003554 PMID: 18978936","journal-title":"PLoS One"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1167\/iovs.13-12730","volume":"54(10)","author":"Cha, D.M.","year":"2013","unstructured":"Cha, D.M.; Woo, S.J.; Kim, H.J.; Lee,C.; Park, K.H. Com-parative analysis of aqueous humor cytokine levels between patients with exudative age-related macular degeneration and normal controls. Invest. Ophthalmol. Vis. Sci. 2013,54(10),7038-7044. http:\/\/dx.doi.org\/10.1167\/iovs.13-12730 PMID: 24106111","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=91","first-page":"352","volume":"22","author":"Liu,F.","year":"2016","unstructured":"Liu,F.; Ding,X.; Yang,Y.; Li,J.; Tang,M.; Yuan,M.; Hu,A.; Zhan,Z.; Li,Z.; Lu, L. Aqueous humor cytokine profil-ing in patients with wet AMD. Mol. Vis. 2016,22,352-361 PMID: 27122966","journal-title":"Mol..Vis"},{"key":"ref=92","first-page":"234","volume":"18","author":"Sung, H.J.","year":"2012","unstructured":"Sung, H.J.; Han, J.I.; Lee, J.W.; Uhm, K.B.; Heo, K. TCCR\/WSX-1 is a novel angiogenic factor in age-related macular degeneration. Mol. Vis. 2012,18,234-240 PMID: 22312192","journal-title":"Mol..Vis"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.2174\/092986706778773086","volume":"13(27)","author":"Wilkinson-Berka, J.L.","year":"2006","unstructured":"Wilkinson-Berka, J.L.; Wraight,C.; Werther, G. The role of growth hormone, insulin-like growth factor and soma-tostatin in diabetic retinopathy. Curr. Med. Chem. 2006,13(27),3307-3317. http:\/\/dx.doi.org\/10.2174\/092986706778773086 PMID: 17168853","journal-title":"Curr.Med.Chem"},{"key":"ref=94","first-page":"1658","volume":"18","author":"Ecker, S.M.","year":"2012","unstructured":"Ecker, S.M.; Pfahler, S.M.; Hines, J.C.; Lovelace, A.S.; Glaser, B.M. Sequential in-office vitreous aspirates demon-strate vitreous matrix metalloproteinase 9 levels correlate with the amount of subretinal fluid in eyes with wet age-related macular degeneration. Mol. Vis. 2012,18,1658-1667 PMID: 22773904","journal-title":"Mol..Vis"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/archophthalmol.2009.88","volume":"127(5)","author":"Davuluri,G.","year":"2009","unstructured":"Davuluri,G.; Espina,V.; Petricoin, E.F. III.; Ross,M.; Deng,J.; Liotta, L.A.; Glaser, B.M. Activated VEGF recep-tor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for pre-dicting the treatment timing and monitoring response. Arch. Ophthalmol. 2009,127(5),613-621. http:\/\/dx.doi.org\/10.1001\/archophthalmol.2009.88 PMID: 19433709","journal-title":"Arch.Ophthalmol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.yexcr.2013.05.005","volume":"319(13)","author":"Biasutto,L.","year":"2013","unstructured":"Biasutto,L.; Chiechi,A.; Couch,R.; Liotta, L.A.; Espina, V. Retinal pigment epithelium (RPE)  exosomes contain signaling phosphoproteins affected by oxidative stress. Exp. Cell Res. 2013,319(13),2113-2123. http:\/\/dx.doi.org\/10.1016\/j.yexcr.2013.05.005 PMID: 23669273","journal-title":"Exp.Cell Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s40135-013-0037-x","volume":"2(1)","author":"Frederick, P.A.","year":"2014","unstructured":"Frederick, P.A.; Kleinman, M.E. The immune system and AMD. Curr. Ophthalmol. Rep. 2014,2(1),14-19. http:\/\/dx.doi.org\/10.1007\/s40135-013-0037-x PMID: 25110625","journal-title":"Curr.Ophthalmol.Rep"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jaut.2009.09.003","volume":"33(3-4)","author":"Morohoshi,K.","year":"2009","unstructured":"Morohoshi,K.; Goodwin, A.M.; Ohbayashi,M.; Ono, S.J. Autoimmunity in retinal degeneration: autoimmune reti-nopathy and age-related macular degeneration, J. Autoim-mun. 2009,33(3-4),247-254. http:\/\/dx.doi.org\/10.1016\/j.jaut.2009.09.003 PMID: 19846275","journal-title":"Autoim-mun"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yexmp.2011.09.017","volume":"92(1)","author":"Morohoshi,K.","year":"2012","unstructured":"Morohoshi,K.; Patel,N.; Ohbayashi,M.; Chong,V.; Grossniklaus, H.E.; Bird, A.C.; Ono, S.J. Serum autoanti-body biomarkers for age-related macular degeneration and possible regulators of neovascularization. Exp. Mol. Pathol. 2012,92(1),64-73. http:\/\/dx.doi.org\/10.1016\/j.yexmp.2011.09.017 PMID: 22001380","journal-title":"Exp.Mol.Pathol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1590\/S0004-27492007000300030","volume":"70(3)","author":"Damico,F.M","year":"2007","unstructured":"Damico.; F.M. Angiogenesis and retinal diseases. Arq. Bras. Oftalmol. 2007,70(3),547-553. http:\/\/dx.doi.org\/10.1590\/S0004-27492007000300030 PMID: 17768570","journal-title":"Arq.Bras.Oftalmol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"29900","DOI":"10.3390 \/ijms161226211","volume":"16(12)","author":"Lee, Y.M.","year":"2015","unstructured":"Lee, Y.M.; Lee, Y.R.; Kim, C.S.; Jo,K.; Sohn,E.; Kim, J.S.; Kim, J. Effect of guibi-tang, a traditional herbal for-mula, on retinal neovascularization in a mouse model of proliferative retinopathy. Int, J. Mol. Sci. 2015,16(12),29900-29910. http:\/\/dx.doi.org\/10.3390 \/ijms161226211 PMID: 26694358","journal-title":"Int, J.Mol.Sci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12906-016-1216-8","volume":"16","author":"Lee, Y.M.","year":"2016","unstructured":"Lee, Y.M.; Lee, Y.R.; Kim, C.S.; Jo,K.; Sohn,E.; Kim, J.S.; Kim, J. Cnidium officinale extract and bu-tylidenephthalide inhibits retinal neovascularization in vitro and in vivo. BMC Complement. Altern. Med. 2016,16,231. http:\/\/dx.doi.org\/10.1186\/s12906-016-1216-8 PMID: 27435599","journal-title":"BMC Complement.Altern.Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/bjophthalmol-2013-303355","volume":"97(8)","author":"Or,C.","year":"2013","unstructured":"Or,C.; Cui,J.; Matsubara,J.; Forooghian, F. Pro-inflammatory and anti-angiogenic effects of bisphospho-nates on human cultured retinal pigment epithelial cells. Br, J. Ophthalmol. 2013,97(8),1074-1078. http:\/\/dx.doi.org\/10.1136\/bjophthalmol-2013-303355 PMID: 23766431","journal-title":"Br, J.Ophthalmol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","volume":"2","author":"Wong, T.Y.","year":"2016","unstructured":"Wong, T.Y.; Cheung, C.M.; Larsen,M.; Sharma,S.; Simo, R. Diabetic retinopathy. Nat. Rev. Dis. Primers. 2016,2,16012. http:\/\/dx.doi.org\/10.1038\/nrdp.2016.12 PMID: 27159554","journal-title":"Nat.Rev.Dis.Primers"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jdiacomp.2011.11.004","volume":"26(1)","author":"Ola, M.S.","year":"2012","unstructured":"Ola, M.S.; Nawaz, M.I.; Siddiquei, M.M.; Al-Amro,S.; Abu El-Asrar, A.M. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopa-thy, J. Diabetes Complications. 2012,26(1),56-64. http:\/\/dx.doi.org\/10.1016\/j.jdiacomp.2011.11.004 PMID: 22226482","journal-title":"Diabetes Complications"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"3789217","DOI":"10.1155\/2016\/3789217","volume":"2016","author":"Cai,X.","year":"2016","unstructured":"Cai,X.; McGinnis, J.F. Diabetic retinopathy: animal mod-els, therapies, and perspectives, J. Diabetes Res. 2016,2016,3789217. http:\/\/dx.doi.org\/10.1155\/2016\/3789217 PMID: 26881246","journal-title":"Diabetes Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"e16271","DOI":"10.1371\/journal.pone.0016271","volume":"6(1)","author":"VanGuilder, H.D.","year":"2011","unstructured":"VanGuilder, H.D.; Bixler, G.V.; Kutzler,L.; Brucklacher, R.M.; Bronson, S.K.; Kimball, S.R.; Freeman, W.M. Multi-modal proteomic analysis of retinal protein expression al-terations in a rat model of diabetic retinopathy. PLoS One. 2011,6(1),e16271. http:\/\/dx.doi.org\/10.1371\/journal.pone.0016271 PMID: 21249158","journal-title":"PLoS One"},{"key":"ref=108","first-page":"673","volume":"21","author":"Kim, L.A.","year":"2015","unstructured":"Kim, L.A.; Wong, L.L.; Amarnani, D.S.; Bigger-Allen, A.A.; Hu,Y.; Marko, C.K.; Eliott,D.; Shah, V.A.; McGuone,D.; Stemmer-Rachamimov, A.O.; Gai,X.; D\u2019Amore, P.A.; Arboleda-Velasquez, J.F. Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy. Mol. Vis. 2015,21,673-687 PMID: 26120272","journal-title":"Mol..Vis"},{"journal-title":"Eye (Lond.)","author":"Sun,Y.","key":"ref=109","unstructured":"Sun,Y.; Wang,D.; Ye,F.; Hu, D.N.; Liu,X.; Zhang,L.; Gao,L.; Song,E.; Zhang, D.Y. Elevated cell proliferation and VEGF production by high-glucose conditions in Muller cells involve XIAP. Eye (Lond.),2013,27(11),1299-1307. http:\/\/dx.doi.org\/10.1038\/eye.2013.158 PMID: 23928877"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s00125-017-4381-5","volume":"60(10)","author":"Tonade,D.","year":"2017","unstructured":"Tonade,D.; Liu,H.; Palczewski,K.; Kern, T.S. Photorecep-tor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes. Diabetologia. 2017,60(10),2111-2120. http:\/\/dx.doi.org\/10.1007\/s00125-017-4381-5 PMID: 28755268","journal-title":"Diabetologia"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbagen.2017.11.015","volume":"1862(3)","author":"Mugisho, O.O.","year":"2018","unstructured":"Mugisho, O.O.; Green, C.R.; Kho, D.T.; Zhang,J.; Graham, E.S.; Acosta, M.L.; Rupenthal, I.D. The inflammasome pathway is amplified and perpetuated in an autocrine man-ner through connexin43 hemichannel mediated ATP re-lease. Biochim. Biophys. Acta, Gen. Subj. 2018,1862(3),385-393. http:\/\/dx.doi.org\/10.1016\/j.bbagen.2017.11.015 PMID: 29158134","journal-title":"Biochim.Biophys.Acta, Gen.Subj"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/aos.12812","volume":"94(1)","author":"Vujosevic,S.","year":"2016","unstructured":"Vujosevic,S.; Micera,A.; Bini,S.; Berton,M.; Esposito,G.; Midena, E. Proteome analysis of retinal glia cells-related inflammatory cytokines in the aqueous humour of diabetic patients. Acta Ophthalmol. 2016,94(1),56-64. http:\/\/dx.doi.org\/10.1111\/aos.12812 PMID: 26268591","journal-title":"Acta Ophthalmol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1111\/aos.13230","volume":"95(3)","author":"Khuu, L.A.","year":"2017","unstructured":"Khuu, L.A.; Tayyari,F.; Sivak, J.M.; Flanagan, J.G.; Singer,S.; Brent, M.H.; Huang,D.; Tan,O.; Hudson, C. Aqueous humour concentrations of TGF-., PLGF and FGF-1 and total retinal blood flow in patients with early non-proliferative diabetic retinopathy. Acta Ophthalmol. 2017,95(3),e206-e211. http:\/\/dx.doi.org\/10.1111\/aos.13230 PMID: 27678201","journal-title":"Acta Ophthalmol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3109\/02713683.2010.510257","volume":"35(12)","author":"Oh, I.K.","year":"2010","unstructured":"Oh, I.K.; Kim, S.W.; Oh,J.; Lee, T.S.; Huh, K. Inflamma-tory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr. Eye Res. 2010,35(12),1116-1127. http:\/\/dx.doi.org\/10.3109\/02713683.2010.510257 PMID: 21121809","journal-title":"Curr.Eye Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"e0125329","DOI":"10.1371\/journal.pone.0125329","volume":"10(4)","author":"Dong,N.","year":"2015","unstructured":"Dong,N.; Xu,B.; Chu,L.; Tang, X. Study of 27 aqueous humor cytokines in type 2 diabetic patients with or without macular edema. PLoS One. 2015,10(4),e0125329. http:\/\/dx.doi.org\/10.1371\/journal.pone.0125329 PMID: 25923230","journal-title":"PLoS One"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1111\/j.1755-3768.2012.02414.x","volume":"90(5)","author":"Jonas, J.B.","year":"2012","unstructured":"Jonas, J.B.; Tao,Y.; Neumaier,M.; Findeisen, P. Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol. 2012,90(5),e381-e388. http:\/\/dx.doi.org\/10.1111\/j.1755-3768.2012.02414.x PMID: 22490043","journal-title":"Acta Ophthalmol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ajo.2011.02.014","volume":"152(3)","author":"Lange, C.A.K.","year":"2011","unstructured":"Lange, C.A.K.; Stavrakas,P.; Luhmann, U.F O.; de Silva, D.J.; Ali, R.R.; Gregor, Z.J.; Bainbridge, J.W.B. Intraocular oxygen distribution in advanced proliferative diabetic reti-nopathy. Am, J. Ophthalmol. 2011,152(3),406-412. http:\/\/dx.doi.org\/10.1016\/j.ajo.2011.02.014 PMID: 21723532","journal-title":"Am, J.Ophthalmol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10384-011-0004-8","volume":"55(3)","author":"Suzuki,Y.","year":"2011","unstructured":"Suzuki,Y.; Nakazawa,M.; Suzuki,K.; Yamazaki,H.; Mi-yagawa, Y. Expression profiles of cytokines and chemoki-nes in vitreous fluid in diabetic retinopathy and central reti-nal vein occlusion. Jpn, J. Ophthalmol. 2011,55(3),256-263. http:\/\/dx.doi.org\/10.1007\/s10384-011-0004-8 PMID: 21538000","journal-title":"Jpn, J.Ophthalmol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1167\/iovs.08-2736","volume":"50(3)","author":"Reverter, J.L.","year":"2009","unstructured":"Reverter, J.L.; Nadal,J.; Fernandez-Novell, J.M.; Ballester,J.; Ramio-Lluch,L.; Rivera, M.M.; Elizalde,J.; Abengo-echea,S.; Guinovart, J.J.; Rodriguez-Gil, J.E. Tyrosine phosphorylation of vitreous inflammatory and angiogenic peptides and proteins in diabetic retinopathy. Invest. Oph-thalmol. Vis. Sci. 2009,50(3),1378-1382. http:\/\/dx.doi.org\/10.1167\/iovs.08-2736 PMID: 18978347","journal-title":"Invest.Oph-thalmol.Vis.Sci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"e0187304","DOI":"10.1371\/journal.pone.0187304","volume":"12(11)","author":"Klaassen,I.","year":"2017","unstructured":"Klaassen,I.; de Vries, E.W.; Vogels, I.M.C.; van Kampen, A.H.C.; Bosscha, M.I.; Steel, D.H.W.; Van Noorden, C.J.F.; Lesnik-Oberstein, S.Y.; Schlingemann, R.O. Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fi-brovascular membranes. PLoS One. 2017,12(11),e0187304. http:\/\/dx.doi.org\/10.1371\/journal.pone.0187304 PMID: 29095861","journal-title":"PLoS One"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ophtha.2008.09.036","volume":"116(1)","author":"Roh, M.I.","year":"2009","unstructured":"Roh, M.I.; Kim, H.S.; Song, J.H.; Lim, J.B.; Kwon, O.W. Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema. Ophthalmology. 2009,116(1),80-86. http:\/\/dx.doi.org\/10.1016\/j.ophtha.2008.09.036 PMID: 19118699","journal-title":"Ophthalmology"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1167\/iovs.09-4065","volume":"51(5)","author":"Forooghian,F.","year":"2010","unstructured":"Forooghian,F.; Kertes, P.J.; Eng, K.T.; Agron,E.; Chew, E.Y. Alterations in the intraocular cytokine milieu after in-travitreal bevacizumab. Invest. Ophthalmol. Vis. Sci. 2010,51(5),2388-2392. http:\/\/dx.doi.org\/10.1167\/iovs.09-4065 PMID: 20007836","journal-title":"Invest.Ophthalmol.Vis.Sci"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ajo.2011.03.033","volume":"152(4)","author":"Sohn, H.J.","year":"2011","unstructured":"Sohn, H.J.; Han, D.H.; Kim, I.T.; Oh, I.K.; Kim, K.H.; Lee, D.Y.; Nam, D.H. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am, J. Ophthal-mol. 2011,152(4),686-694. http:\/\/dx.doi.org\/10.1016\/j.ajo.2011.03.033 PMID: 21782151","journal-title":"Am, J.Ophthal-mol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00417-017-3819-2","volume":"256(1)","author":"Yu, S.Y.","year":"2018","unstructured":"Yu, S.Y.; Nam, D.H.; Lee, D.Y. Changes in aqueous con-centrations of various cytokines after intravitreal bevacizu-mab and subtenon triamcinolone injection for diabetic macular edema. Graefes Arch. Clin. Exp. Ophthalmol. 2018,256(1),39-47. http:\/\/dx.doi.org\/10.1007\/s00417-017-3819-2 PMID: 29030692","journal-title":"Graefes Arch.Clin.Exp.Ophthalmol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1097\/IAE.0000000000000109","volume":"34(8)","author":"Jeon,S.","year":"2014","unstructured":"Jeon,S.; Lee, W.K. Effect of intravitreal triamcinolone in diabetic macular edema unresponsive to intravitreal bevacizumab. Retina. 2014,34(8),1606-1611. http:\/\/dx.doi.org\/10.1097\/IAE.0000000000000109 PMID: 24553409","journal-title":"Retina"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/173041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T15:09:46Z","timestamp":1605193786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/173041\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":125,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2020,8,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190627131300","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}